(REASON) Double-blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl-l-carnitine in the Prevention of Sagopilone-induced Peripheral Neuropathy
Phase of Trial: Phase II
Latest Information Update: 12 Jul 2019
Price : $35 *
At a glance
- Drugs Levacecarnine (Primary) ; Prednisolone; Prednisone; Sagopilone
- Indications Peripheral neuropathies
- Focus Therapeutic Use
- Acronyms REASON
- Sponsors Bayer; Bayer HealthCare Pharmaceuticals
- 12 Jul 2019 This trial has been completed in France, according to European Clinical Trials Database.
- 31 Aug 2018 Biomarkers information updated
- 08 Feb 2017 New source identified and integrated (ISRCTN75009754; ISRCTN: Current Controlled Trials).